Literature DB >> 35693978

Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines.

A A Dolskiy1, I V Grishchenko1, S A Bodnev1, A A Nazarenko1, A M Smirnova1, A K Matveeva1, L E Bulychev1, A S Ovchinnikova1, T V Tregubchak1, A V Zaykovskaya1, I R Imatdinov1, O V Pyankov1, E V Gavrilova1, R A Maksyutov1, D V Yudkin1.   

Abstract

Coronaviridae is a family of single-stranded RNA (ssRNA) viruses that can cause diseases with high mortality rates. SARS-CoV-1 and MERS-CoV appeared in 2002‒2003 and 2012, respectively. A novel coronavirus, SARS-CoV-2, emerged in 2019 in Wuhan (China) and has caused more than 5 million deaths in worldwide. The entry of SARS-CoV-1 into the cell is due to the interaction of the viral spike (S) protein and the cell protein, angiotensin-converting enzyme 2 (ACE2). After infection, virus assembly occurs in Golgi apparatus-derived vesicles during exocytosis. One of the possible participants in this process is LAMP1 protein. We established transgenic Vero cell lines with increased expression of human LAMP1 gene and evaluated SARS-CoV-1 and SARS-CoV-2 production. An increase in the production of both viruses in LAMP1-expressing cells when compared with Vero cells was observed, especially in the presence of trypsin during infection. From these results it can be assumed that LAMP1 promotes SARS-CoV-1 and SARS-CoV-2 production due to enhanced exocytosis. © Pleiades Publishing, Inc. 2022, ISSN 0026-8933, Molecular Biology, 2022, Vol. 56, No. 3, pp. 463–468. © Pleiades Publishing, Inc., 2022.Russian Text
© The Author(s), 2022, published in Molekulyarnaya Biologiya, 2022, Vol. 56, No. 3, pp. 503–509.

Entities:  

Keywords:  COVID-19; LAMP1; SARS-CoV-1; SARS-CoV-2; Vero; transgenic cells

Year:  2022        PMID: 35693978      PMCID: PMC9165926          DOI: 10.1134/S0026893322030050

Source DB:  PubMed          Journal:  Mol Biol        ISSN: 0026-8933            Impact factor:   1.540


  21 in total

1.  Another formula for calculating the gene change rate in real-time RT-PCR.

Authors:  Shujian Chang; Weichang Chen; Jicheng Yang
Journal:  Mol Biol Rep       Date:  2008-12-25       Impact factor: 2.316

2.  Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication.

Authors:  Eric C Mossel; Cheng Huang; Krishna Narayanan; Shinji Makino; Robert B Tesh; C J Peters
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero).

Authors:  J Desmyter; J L Melnick; W E Rawls
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

4.  The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.

Authors:  Stefanie Gierer; Stephanie Bertram; Franziska Kaup; Florian Wrensch; Adeline Heurich; Annika Krämer-Kühl; Kathrin Welsch; Michael Winkler; Benjamin Meyer; Christian Drosten; Ulf Dittmer; Thomas von Hahn; Graham Simmons; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

5.  A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs.

Authors:  Vithiagaran Gunalan; Ali Mirazimi; Yee-Joo Tan
Journal:  BMC Res Notes       Date:  2011-10-25

6.  The genome landscape of the african green monkey kidney-derived vero cell line.

Authors:  Naoki Osada; Arihiro Kohara; Toshiyuki Yamaji; Noriko Hirayama; Fumio Kasai; Tsuyoshi Sekizuka; Makoto Kuroda; Kentaro Hanada
Journal:  DNA Res       Date:  2014-09-28       Impact factor: 4.458

Review 7.  Origin and evolution of pathogenic coronaviruses.

Authors:  Jie Cui; Fang Li; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

8.  The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.

Authors:  Shuai Xia; Qiaoshuai Lan; Shan Su; Xinling Wang; Wei Xu; Zezhong Liu; Yun Zhu; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2020-06-12

Review 9.  Emerging coronaviruses: Genome structure, replication, and pathogenesis.

Authors:  Yu Chen; Qianyun Liu; Deyin Guo
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

10.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.